ModivCare Inc MODV.OQ MODV.O is expected to show a fall in quarterly revenue when it reports results on August 5 (estimated) for the period ending June 30 2025
The Denver Colorado-based company is expected to report a 6.5% decrease in revenue to $653.218 million from $698.3 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for ModivCare Inc is for a loss of 54 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for ModivCare Inc is $1.98, about 46.3% below its last closing price of $2.89
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.45 | -0.50 | -1.71 | Missed | -242 |
Dec. 31 2025 | -0.02 | 0.18 | 0.19 | Beat | 8 |
Sep. 30 2024 | 0.58 | 0.78 | 0.45 | Missed | -41.9 |
Jun. 30 2024 | 0.80 | 0.77 | -0.03 | Missed | -103.9 |
Mar. 31 2024 | 0.24 | 0.19 | -0.09 | Missed | -146.6 |
Dec. 31 2023 | 1.32 | 1.28 | 1.29 | Beat | 0.9 |
Sep. 30 2023 | 1.17 | 1.11 | 1.44 | Beat | 29.3 |
Jun. 30 2023 | 1.71 | 1.62 | 1.47 | Missed | -9.3 |
This summary was machine generated August 1 at 11:09 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。